Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTempleton Emerging Markets Regulatory News (TEM)

Share Price Information for Templeton Emerging Markets (TEM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 157.80
Bid: 157.60
Ask: 157.80
Change: 1.80 (1.15%)
Spread: 0.20 (0.127%)
Open: 156.80
High: 158.40
Low: 156.80
Prev. Close: 156.00
TEM Live PriceLast checked at -
Templeton Emerging Markets is an Investment Trust

To provide long-term capital appreciation for private and institutional investors seeking exposure to global emerging markets, supported by both strong customer service and corporate governance.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison review on Templeton Emerging Markets IT

18 Jun 2020 16:16

RNS Number : 4211Q
Templeton Emerging Markets IT PLC
18 June 2020
 

 

London, UK, 18 June 2020

Edison review on Templeton Emerging Markets IT (TEM)

Templeton Emerging Markets Investment Trust's (TEMIT) two managers have more than 50 years' combined investment experience. Chetan Sehgal is based in Singapore and Andrew Ness is based in Edinburgh; they are part of a more than 80-strong team of portfolio managers and analysts across 16 countries around the globe. The trust's relative performance was negatively affected during the coronavirus-led market sell-off earlier in 2020 but has since bounced back strongly. TEMIT has outperformed its benchmark, the MSCI Emerging Markets index, over the last one, three, five and 10 years in both NAV and share price terms.

 

TEMIT's current 11.6% discount to cum-income NAV is broadly in line with the 10.3% to 12.1% range of average discounts over the last one, three, five and 10 years. Over the last 12 months the trust has traded in a range of discounts from 8.7% to a decade-wide 19.9%. TEMIT has meaningfully grown its annual dividends in recent years and currently offers a 2.5% yield.

Click here to view the full report.

 

Subscribe to Edison's content to receive reports by email.

All reports published by Edison are free-to-access and available on the website.

 

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Mel Jenner, +44 (0)20 3077 5720

Sarah Godfrey, +44 (0)20 3681 2519

investmenttrusts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group- 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAEVLFFBQLFBBZ
Date   Source Headline
16th May 20234:58 pmRNSTransaction in Own Shares
16th May 20239:07 amRNSNet Asset Value(s)
15th May 20239:05 amRNSNet Asset Value(s)
12th May 20234:58 pmRNSTransaction in Own Shares
12th May 20239:08 amRNSNet Asset Value(s)
11th May 20234:57 pmRNSTransaction in Own Shares
11th May 20238:57 amRNSNet Asset Value(s)
10th May 20239:23 amRNSNet Asset Value(s)
9th May 20234:57 pmRNSTransaction in Own Shares
9th May 20239:24 amRNSNet Asset Value(s)
9th May 20239:07 amRNSCompliance with MAR, Article 19, Paragraph 11
5th May 20234:59 pmRNSTransaction in Own Shares
5th May 20239:20 amRNSNet Asset Value(s)
4th May 20239:13 amRNSNet Asset Value(s)
3rd May 20234:56 pmRNSTransaction in Own Shares
3rd May 20239:13 amRNSNet Asset Value(s)
2nd May 20235:01 pmRNSTransaction in Own Shares
2nd May 20239:45 amRNSNet Asset Value(s)
2nd May 20238:46 amRNSTotal Voting Rights
28th Apr 20239:37 amRNSNet Asset Value(s)
27th Apr 20238:56 amRNSNet Asset Value(s)
26th Apr 20238:49 amRNSNet Asset Value(s)
25th Apr 20234:53 pmRNSTransaction in Own Shares
25th Apr 20239:02 amRNSNet Asset Value(s)
24th Apr 20234:52 pmRNSTransaction in Own Shares
24th Apr 20238:46 amRNSNet Asset Value(s)
21st Apr 20234:49 pmRNSTransaction in Own Shares
21st Apr 20239:02 amRNSNet Asset Value(s)
20th Apr 20234:51 pmRNSTransaction in Own Shares
20th Apr 20238:56 amRNSNet Asset Value(s)
20th Apr 20237:42 amRNSPortfolio Update
19th Apr 20234:58 pmRNSTransaction in Own Shares
19th Apr 20238:55 amRNSNet Asset Value(s)
18th Apr 20234:49 pmRNSTransaction in Own Shares
18th Apr 20239:01 amRNSNet Asset Value(s)
17th Apr 20234:50 pmRNSTransaction in Own Shares
17th Apr 20239:24 amRNSNet Asset Value(s)
14th Apr 20235:00 pmRNSTransaction in Own Shares
14th Apr 20238:51 amRNSNet Asset Value(s)
13th Apr 20234:58 pmRNSTransaction in Own Shares
13th Apr 20239:09 amRNSNet Asset Value(s)
12th Apr 20235:02 pmRNSTransaction in Own Shares
12th Apr 20239:01 amRNSNet Asset Value(s)
11th Apr 202310:00 amRNSNet Asset Value(s)
6th Apr 20234:56 pmRNSTransaction in Own Shares
6th Apr 20239:28 amRNSNet Asset Value(s)
5th Apr 20235:00 pmRNSTransaction in Own Shares
5th Apr 20239:46 amRNSNet Asset Value(s)
4th Apr 20235:04 pmRNSTransaction in Own Shares
4th Apr 20239:36 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.